Position in DNLI
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$0
-$106,954 QoQ
Shares Held
0
-100.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
10 quarters on record
Common Shares in DNLI Over Time
Shares Held
Position Value (USD)
Derivatives in DNLI
reported options exposure · as of Mar 31, 2026CallValue
$3,129,600
CallShares
163,000
PutValue
$1,432,320
PutShares
74,600
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Caption Management, LLC holds $249,760,911 across 78 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CGON |
CG Oncology, Inc.
|
484,461 | $34,420,954 | |
| 2 | INSM |
INSMED Inc
|
236,000 | $25,162,320 | |
| 3 | ERAS |
Erasca, Inc.
|
1,041,225 | $19,075,242 | |
| 4 | CELC |
Celcuity Inc.
|
170,000 | $17,785,400 | |
| 5 | DSGN |
Design Therapeutics, Inc.
|
1,118,098 | $16,178,878 | |
| 6 | MLYS |
Mineralys Therapeutics, Inc.
|
413,087 | $11,145,087 | |
| 7 | REPL |
Replimune Group, Inc.
|
783,873 | $8,677,474 | |
| 8 | TARS |
Tarsus Pharmaceuticals, Inc.
|
120,700 | $7,596,858 |
All Filings in DNLI
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,129,600 | 163,000 | Call | Sole | 2026-05-15 | |
| 2026-03-31 | $1,432,320 | 74,600 | Put | Sole | 2026-05-15 | |
| 2025-09-30 | $435,600 | 30,000 | Put | Sole | 2025-11-14 | |
| 2025-09-30 | $1,324,224 | 91,200 | Call | Sole | 2025-11-14 | |
| 2025-09-30 | $106,954 | 7,366 | Shares | Sole | 2025-11-14 | |
| 2024-12-31 | $611,400 | 30,000 | Call | Sole | 2025-02-14 | |
| 2024-12-31 | $611,400 | 30,000 | Put | Sole | 2025-02-14 | |
| 2024-12-31 | $405,562 | 19,900 | Shares | Sole | 2025-02-14 | |
| 2024-06-30 | $696,600 | 30,000 | Put | Sole | 2024-08-14 | |
| 2024-06-30 | $696,600 | 30,000 | Call | Sole | 2024-08-14 | |
| 2023-12-31 | $64,380 | 3,000 | Shares | Sole | 2024-02-14 | |
| 2023-12-31 | $643,800 | 30,000 | Call | Sole | 2024-02-14 | |
| 2023-12-31 | $643,800 | 30,000 | Put | Sole | 2024-02-14 | |
| 2023-09-30 | $618,900 | 30,000 | Call | Sole | 2023-11-14 | |
| 2023-09-30 | $618,900 | 30,000 | Put | Sole | 2023-11-14 | |
| 2021-12-31 | $1,338,000 | 30,000 | Call | Sole | 2022-02-11 | |
| 2021-12-31 | $1,338,000 | 30,000 | Put | Sole | 2022-02-11 | |
| 2021-09-30 | $2,835,290 | 56,200 | Put | Sole | 2021-11-12 | |
| 2021-09-30 | $9,156,675 | 181,500 | Call | Sole | 2021-11-12 | |
| 2021-06-30 | $21,712,192 | 276,800 | Call | Sole | 2021-08-16 | |
| 2021-06-30 | $2,353,200 | 30,000 | Put | Sole | 2021-08-16 | |
| 2020-12-31 | $3,141,000 | 37,500 | Call | Sole | 2021-02-16 | |
| 2020-12-31 | $3,141,000 | 37,500 | Put | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||